Warrants and Derivatives - Additional Information (Details) - USD ($) $ in Thousands |
3 Months Ended | |
|---|---|---|
Mar. 31, 2024 |
Mar. 31, 2023 |
|
| Class of Warrant or Right [Line Items] | ||
| Proceeds from sale and issuance of equity | $ 25,000 | |
| Warrants to purchase common stock | 84,541,731 | |
| Third party issuance costs | $ 44 | |
| FP Combination Warrants | ||
| Class of Warrant or Right [Line Items] | ||
| warrant exercise right to redeem in cash | 25,000 | |
| Equity-classified Warrants and Derivatives | ||
| Class of Warrant or Right [Line Items] | ||
| Changes in warrants and derivatives | $ 0 | $ 0 |
| Liability-classified warrants and derivatives | ||
| Class of Warrant or Right [Line Items] | ||
| Changes in warrants and derivatives | $ 0 | |
| X | ||||||||||
- Definition Increase decrease in warrants and derivatives. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The cash outflow for cost incurred directly with the issuance of an equity security. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The cash inflow associated with the amount received from holders exercising their stock warrants. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|